Kinetic mechanism of dopamine transporter interaction with 1-(2-(bis-(4-fluorophenyl)methoxy)ethyl)-4-(3-phenylpropyl)piperazine (GBR 12909)

被引:6
|
作者
Stepanov, Vladimir [1 ]
Jarv, Jaak [1 ]
机构
[1] Univ Tartu, Inst Chem, EE-51014 Tartu, Estonia
关键词
Dopamine transporter; Transporter inhibitor; GBR12909; PE21; Ligand binding mechanism; Ligand binding kinetics; Isomerisation;
D O I
10.1016/j.neuint.2008.09.005
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Interaction of piperazine-based dopamine transporter inhibitor GBR12909 with rat dopamine transporters has been Studied by means of competition kinetics analysis, employing [(3)H]PE21 as the reporter ligand. It has been found that GBR12909 is capable of inducing so-called "slow isomerization step" upon binding to DAT, probably consisting of a conformational change in the transporter protein. The mechanism exhibited by GBR12909 appears to be similar to the mechanism ofPE21 that has been reported earlier and also confirms previous observations for GBR12783 made by Do-Rego and co-workers using dopamine uptake data. it appears that the isomerization phenomenon previously described for PE21 is not limited to tropane-based DAT inhibitors, but is,in fact,a general property of dopamine transporterprotein, similar to "isomerization" process reported previously for G-protein Coupled receptors. The rapid first step of association of the GBR 12909 is characterized by the equilibrium constant K(L) = 34 +/- 11 nM and the second slow step by k(i) = 0.033 +/- 0.005 s(-1). (C) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码:370 / 373
页数:4
相关论文
共 50 条
  • [41] Specific binding of 1-[2-(diphenylmethoxy)ethyl]-4-(3-phenyl propyl) piperazine (GBR-12935), an inhibitor of the dopamine transporter, to human CYP2D6
    Hiroi, T
    Imaoka, S
    Chow, T
    Yabusaki, Y
    Funae, Y
    BIOCHEMICAL PHARMACOLOGY, 1997, 53 (12) : 1937 - 1939
  • [42] EFFECTS OF (E)-1-[BIS(4-FLUOROPHENYL)METHYL]-4-(3-PHENYL-2-PROPENYL) PIPERAZINE DIHYDROCHLORIDE (FLUNARIZINE) ON CEREBRAL-CIRCULATION
    KUBO, K
    KARASAWA, A
    YAMADA, K
    NITO, M
    SHUTO, K
    NAKAMIZO, N
    FOLIA PHARMACOLOGICA JAPONICA, 1982, 79 (05) : 383 - 400
  • [43] First catalytic enantioselective synthesis of the cocaine abuse therapeutic agent (S)-(+)-1-(4-{2-[bis(4-fluorophenyl)methoxy]ethyl}-piperazin-1-yl)-2-phenyl-2-propanol
    Forrat, Vicente J.
    Ramon, Diego J.
    Yus, Miguel
    TETRAHEDRON-ASYMMETRY, 2007, 18 (03) : 400 - 405
  • [44] Synthesis of 1-(3-Phenylpropyl)-4-(pyridinylmethoxy)-[1,2,4]triazolo[4,3-a] quinoxalines
    Summer, Dominik
    Matuszczak, Barbara
    LETTERS IN ORGANIC CHEMISTRY, 2019, 16 (01) : 25 - 29
  • [45] 1-(3,4-Dihydroxyphenyl)-2-(4-fluorophenyl)ethanone
    Song, Xiao-Qing
    ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, 2008, 64 : O2282 - U1808
  • [46] Expansion of structure-activity studies of piperidine analogues of 1-[2-(diphenylmethoxy)ethyl]-4-(3-phenylpropyl)piperazine (GBR 12935) compounds by altering substitutions in the N-benzyl moiety and behavioral pharmacology of selected molecules
    Dutta, AK
    Davis, MC
    Fei, XS
    Beardsley, PM
    Cook, CD
    Reith, MEA
    JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (03) : 654 - 662
  • [47] Ethyl 2,6-bis(4-chlorophenyl)-4-(4fluoroanilino)-1-(4-fluorophenyl)1,2,5,6-tetrahydropyridine-3-carboxylate
    Anthal, Sumati
    Brahmachari, Goutam
    Das, Suvankar
    Kant, Rajni
    Gupta, Vivek K.
    ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2013, 69 : O506 - +
  • [48] Enantioselective synthesis of S-(+)-2β-carboalkoxy-3α-[bis(4-fluorophenyl)methoxy]tropanes as novel probes for the dopamine transporter
    Zou, MF
    Agoston, GE
    Belov, Y
    Kopajtic, T
    Katz, JL
    Newman, AH
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2002, 12 (09) : 1249 - 1252
  • [49] 4-[2-(4-Fluorophenyl)-1H-pyrrol-3-yl]pyridine
    Abu Thaher, Bassam
    Koch, Pierre
    Schollmeyer, Dieter
    Laufer, Stefan
    ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, 2009, 65 : O457 - U1226
  • [50] Ether modifications to 1-[2-(3,4-dimethoxyphenyl)ethyl]-4-(3-phenylpropyl)piperazine (SA4503): Effects on binding affinity and selectivity for sigma receptors and monoamine transporters
    Xu, Rong
    Lord, Sarah A.
    Peterson, Ryan M.
    Fergason-Cantrell, Emily A.
    Lever, John R.
    Lever, Susan Z.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2015, 23 (01) : 222 - 230